ISSUE 1420
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
The FDA has approved use of Kcentra (CSL Behring), a human-derived 4-factor prothrombin complex concentrate (PCC), for urgent reversal of warfarin anticoagulation in adults with acute major bleeding. It is the only 4-factor PCC available in the US.
PROTHROMBIN COMPLEX CONCENTRATES — The vitamin K-dependent coagulation factors are II, VII, IX and X. The composition of PCC products is variable. Three-factor PCC products include clotting factors II, IX and X, but contain little or no factor VII. Four-factor PCCs, which have been available in Europe and Canada for many years, include significant amounts of factor VII.1
REVERSING WARFARIN — Warfarin-related bleeding can be catastrophic, but it is reversible.2 Vitamin K can take more than 24 hours to fully restore vitamin K-dependent coagulation factors. Fresh-frozen
... moreWould you like to read the rest of this article? Gain access below.
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Article code: 1420a
Electronic, downloadable article - $45